CPRI
13.84 USD
+0.74%
Today
-0.44%
1D
Market is open
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 12:00 PM
Sat
Closed
Information
Name
Capri Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
Market Cap
411.62M
Avg Daily Volume
4.47M
52 Week High
40.37 USD
52 Week Low
2.96 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.
Top News
Capri
-0.44%
CAPR Stock Sinks As Investors Brace For Imminent FDA Call On Deramiocel
tradingview.com
2d ago
Capri
-0.44%
Activist Investor Sounds Alarm on Capricor’s Cash Burn
tradingview.com
2d ago
Capri
-0.44%
Capricor Draws Investor Attention As Shareholder Kaos Capital Pushes For Board Shakeup Ahead Of Key FDA Decision On DMD Therapy
tradingview.com
2d ago
Show more
Frequently Asked Questions
What are cyclical stocks in trading?
Cyclicals are stocks that move in line with the broader economy. They perform well during economic booms and tend to decline during recessions.
Why do traders invest in cyclical sectors?
Traders use cyclicals to capitalize on economic recovery phases, often seeking high returns when consumer spending and business investment rise.
What industries fall under cyclicals?
Automobiles, travel & tourism, retail, restaurants, and luxury goods are common cyclical industries.
Are cyclical stocks risky?
They can be. While they offer growth potential, they are more volatile and sensitive to economic changes compared to defensive sectors.
